GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 89 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $588,000 | +224.9% | 41,435 | -5.4% | 0.10% | +171.4% |
| Q1 2020 | $181,000 | +36.1% | 43,817 | +134.3% | 0.04% | +59.1% |
| Q1 2019 | $133,000 | -12.5% | 18,703 | -21.8% | 0.02% | -4.3% |
| Q2 2018 | $152,000 | -25.9% | 23,903 | +37.2% | 0.02% | -58.2% |
| Q3 2016 | $205,000 | +48.6% | 17,422 | -1.9% | 0.06% | +31.0% |
| Q4 2015 | $138,000 | – | 17,756 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 950,000 | $9,823,000 | 1.01% |
| Curi RMB Capital, LLC | 939,265 | $9,720,000 | 0.74% |
| KOPP INVESTMENT ADVISORS LLC | 96,384 | $997,000 | 0.39% |
| Alyeska Investment Group, L.P. | 314,502 | $3,254,000 | 0.16% |
| PFM Health Sciences, LP | 604,199 | $6,252,000 | 0.13% |
| Spark Investment Management LLC | 47,000 | $485,000 | 0.13% |
| ELLINGTON MANAGEMENT GROUP LLC | 61,700 | $638,000 | 0.12% |
| PUTNAM INVESTMENTS LLC | 1,745,494 | $18,048,000 | 0.05% |
| PointState Capital LP | 298,976 | $3,094,000 | 0.05% |
| Partner Investment Management, L.P. | 20,717 | $214,000 | 0.05% |